August 26, 2015
ASKA Pharmaceutical will launch authorized generic (AG) versions of Takeda Pharmaceutical’s hypertension drug Unisia, a fixed-dose combination of the angiotensin receptor blocker (ARB) Blopress (candesartan) and the calcium channel blocker (CCB) amlodipine, the two companies said on August 25. The...read more